Cite
MLA Citation
S.A. Maxwell et al.. “DEVELOPMENT OF NOVEL, NON‐TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).” Hematological oncology, vol. 35, n.d., pp. 253–254. http://access.bl.uk/ark:/81055/vdc_100047519508.0x000034